Image

Evaluation of Lacrifill

Evaluation of Lacrifill

Recruiting
18-80 years
All
Phase 4

Powered by AI

Overview

Dry Eye Disease is defined as "a multifactorial disease of the tears and ocular surface that results in symptoms of discomfort, visual disturbance, and tear film instability with potential damage to the ocular surface. It is accompanied by increased osmolarity of the tear film and inflammation of the ocular surface.' 'By the The Tear Film and Ocular Surface Society. Despite there being a number of factors that impact DED however one factor that has been considered likely is that of a complication from ocular surgery itself. Which can cause both corneal nerve, and ocular surface damage. Therefore this study aims to determine how Lacrfill performs in preventing post-operative dry eye symptoms in those who have recently had unilateral cataract surgery.

Eligibility

Inclusion Criteria:

  • Adults ≥18 years of age.
  • Have the potential of 20/40 visual acuity or better post-cataract surgery.
  • have cataract surgery scheduled for both eyes
  • Corneal staining score of ≥3 on the original National Eye Institute (NEI; 0-15 total score) staining scale in the study eye.
  • willing to discontinue contact lens throughout the study?
  • pre-treatment OSDI scores of ≤12 (asymptomatic)?

Exclusion Criteria:

  • Known systemic health conditions that are known to alter tear film physiology (e.g., primary and secondary Sjögren's syndrome)?
  • History of ocular surgery within the past 12 months (excluding cataract surgery)
  • Anticipated complications from cataract surgery in either eye?
  • History of severe ocular trauma, active ocular infection or inflammation that is not dry eye-related?
  • Used Accutane or is currently using ocular medications/treatments outside of study treatments? Artificial tears will be allowed.
  • Physical meibomian gland treatment withing 1 month of enrollment?
  • Having any conditions or are in a situation, which in the investigator's opinion, may put the subject at significant risk, may confound the study results, or may significantly interfere with their participation in the study.
  • Currently pregnant or breast feeding

Study details
    Dry Eye
    Ocular Surface Disease
    Cataract Surgery
    Eyes Dry Feeling of

NCT07796178

Eye Research Associates, LLC

26 September 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.